LabTurbo Biotech Corporation

LabTurbo Biotech Corporation is a molecular diagnostics and laboratory automation company specializing in fully automated nucleic acid extraction and qPCR solutions for high-complexity laboratories and healthcare providers. The company manufactures integrated and standalone extraction/qPCR platforms alongside consumable kits (DNA/RNA extraction, PCR panels) designed for high-throughput, hands-off workflows. LabTurbo serves clinical laboratories with rapid PCR diagnostic testing panels targeting COVID-19, influenza, RSV, respiratory pathogens, UTI, STD, gastrointestinal, and pharmacogenomics (PGx) applications. The product portfolio includes fully automated systems (AIO 48 SP-qPCR, 48 Extraction System, QuadAIO point-of-care), manual extraction platforms (VacEZor), and validated consumable kits. The company has received recognition including the 2022 Biotech Industry Award and National Innovation Award for excellence in automated gene testing and nucleic acid detection.